(Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders. Presented in partnership with global data firm Statista, the inaugural ranking recognizes the ...

Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc.

(Nasdaq: CTKB) announced today that its Cytek ® Muse ® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards. The annual program, conducted by ...

Antibodies serve as foundational tools across a broad range of research fields from immunology to oncology and infectious ...

Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.

Early CAR T cell expansion is associated with both therapeutic activity and inflammatory toxicity, such as cytokine release syndrome and neurotoxicity. Routine flow cytometry can reliably track ...

FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. ...

The assay is fast and simple and has already shown clinical utility, although its interpretation may be limited by reference ...

Vibrant stripes of color — red, orange, yellow, green, blue, and violet — merge beneath a clear case. A celebration of color, ...

The company raised guidance by $25 million each for total revenue, adjusted EBITDA, and free cash flow to approximately $8.525 billion in revenue, $2.625 billion in adjusted EBITDA, and $1.225 billion ...

Glioblastoma—the most aggressive form of brain cancer—remains one of medicine's biggest challenges. Despite surgery, ...

Circ-EGFR was identified as a novel predictive biomarker for cetuximab efficacy in KRAS wild-type metastatic colorectal ...